New A.I.D.S. Drugs (Press, 3 October 1986)

On 3 October 1986, two new anti-AIDS drugs named CSBS and ST were announced at a conference in New Orleans by Dr Raymond Schinazi. These drugs are claimed to prolong the lives of AIDS patients without the dangerous side effects commonly associated with other treatments. Their announcement follows the recent approval by the United States Government of a similar drug, AZT, which has been made available to a limited number of patients. Dr Schinazi highlighted that CSBS and ST have significantly low toxicity, making them viable options for a broader range of patients, including children and those who have developed antibodies to HIV but do not yet have full-blown AIDS. This distinguishes them from AZT, which is not suitable for pregnant women, children, and certain other patient categories due to its side effects. The new drugs are set to undergo human trials in the following year. Dr Schinazi's statement underscored that while CSBS and ST show promise, they should not be viewed as a cure for AIDS but rather as a beneficial treatment option for those in need. Meanwhile, the approval process for AZT will see it distributed to approximately 6,000 to 7,000 AIDS patients under the guidelines established by the Food and Drug Administration. Published information indicates that the availability of these drugs is a significant step forward in the fight against the AIDS epidemic, providing hope and treatment options to many affected individuals.

The text on this page is created, in the most part, using Generative AI and so may contain errors or omissions. It is supplied to you without guarantee or warranty of correctness. If you find an error or would like to make a content suggestion please get in contact

The text on this page is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 3.0 New Zealand